Management of prostate cancer in older patients.
|
| Abstract |
The incidence of prostate cancer among older men has increased in many countries, including Asian countries. However, older patients are ineligible for inclusion in large randomized trials, and the existing guidelines for the management of patients with prostate cancer do not provide specific treatment recommendations for older men. Therefore, generation of evidence for older patients with prostate cancer is a key imperative. The International Society of Geriatric Oncology has produced and updated several guidelines for management of prostate cancer in older men since 2010. Regarding localized prostate cancer, both surgery and radiotherapy are considered as feasible treatment options for intermediate- and high-risk prostate cancer even in older men, whereas watchful waiting and active surveillance are useful options for a proportion of these patients. With regard to advanced disease, androgen-receptor axis targets and taxane chemotherapy are standard treatment modalities, although dose modification and prevention of adverse events need to be considered. Management strategy for older patients with prostate cancer should take cognizance of not only the chronological age but also psychological and physical condition, socio-economic status and patient preferences. Geriatric assessment and patient-reported health-related quality of life are important tools for assessing health status of older patients with prostate cancer; however, there is a paucity of evidence of the impact of these tools on the clinical outcomes. Personalized management according to the patient's health status and tumour characteristics as well as socio-economic condition may be necessary for treatment of older patients with prostate cancer.
|
|---|---|
| Authors | Shintaro Narita, Shingo Hatakeyama, Shinichi Sakamoto, Takuma Kato, Juichi Inokuchi, Yoshiyuki Matsui, Hiroshi Kitamura, Hiroyuki Nishiyama, Tomonori Habuchi |
| Journal | Japanese journal of clinical oncology (Jpn J Clin Oncol) Vol. 52 Issue 6 Pg. 513-525 (May 31 2022) ISSN: 1465-3621 [Electronic] England |
| PMID | 35217872 (Publication Type: Journal Article) |
| Copyright | © The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: [email protected]. |
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!